New Double-Targeting drug enters first human test for severe lupus
Disease control
Recruiting now
This is a first-in-human study to test the safety and find the right dose of a new drug, HB2198, for people with moderate to severe lupus. About 30 participants with active lupus, including kidney involvement, will receive two doses of the drug and be followed for a year. The mai…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC